Skip to content
Saturday, July 05, 2025
  • Home
  • BCS News
    • Latest from BCS
    • BCS Editorials
    • Obituaries
    • Editors
  • COVID-19
  • BCS Home
Image of Heart shaped leaves on a plant for In Memory
News

Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve

CardioNewsUK 20 November 2020 Atrial FibrillationCardiologyResearch

Important data from Brazil demonstrating the safety and non inferiority of DOAC therapy in biological mitral valves and atrial fibrillation. This study makes a significant contribution to understand the ‘valvular’ AF story.

Post navigation

Previous Previous post: N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects
Next Next post: CaReMe Heart Failure in Adults: Diagnosis & Management Algorithm

Video

https://youtu.be/jpDhCKcM7ak

RSS Heart Journal

  • Cardiovascular screening and long-term outcomes in aircraft pilots
  • Epicardial adipose tissue, myocardial remodelling and adverse outcomes in asymptomatic aortic stenosis: a post hoc analysis of a randomised controlled trial
  • Advancing clinical management of left ventricular thrombosis: prevention, detection and treatment modalities in the modern era
  • Dysglycaemia and incident aortic stenosis: a cohort study
  • Distinct early repolarisation patterns in male Brazilian soccer players: insights from a multicentre study

RSS AHA Journal Feed

  • Risk of Poststroke Dementia in Patients With and Without Atrial Fibrillation: A Nationwide Cohort Study
  • Long‐Term Incidence of Dementia Following Transient Ischemic Attack: A Longitudinal Cohort Study
  • Artificial Intelligence–Enabled ECGs for Atrial Fibrillation Identification and Enhanced Oral Anticoagulant Adoption: A Pragmatic Randomized Clinical Trial
  • Renal Function and its Time‐Sensitive Influence on Survival Rates of Acute Myocardial Infarction
  • Effect of Medical Therapy on Reducing the Risk of Pacing‐Induced Cardiomyopathy
UK Cardiology News |
British Cardiovascular Society
✕
BCS Heartbeat

FREE
VIEW